2: Clorox Healthcare Products Receive Additional EPA-Registered Kill Claims for Bacterial and Viral Pathogens
In the battle against healthcare-associated infections, infection prevention measures are of the utmost importance. To this end, Clorox Healthcare recently announced that their Bleach Germicidal Wipes are now EPA-registered to kill 58 microorganisms in three minutes or less, and Clorox Healthcare Bleach Germicidal Cleaners are EPA-registered to kill 50 microorganisms in three minutes or less. Furthermore, the wipes and cleaners effectively eliminated the bacterial spores within a three-part soil load, as per interim guidance set by the EPA in 2014.
Each year, millions of individuals become infected with Clostridium difficile, which can cause severe diarrhea, and is deemed an “urgent threat” by the CDC. According to the CDC, C. diff
infects approximately 250,000 individuals annually; in addition, a total of 14,000 of these individuals will die from infection each year.
infections are mainly associated with antibiotic use, and occur in patients either during their hospital stay or after their release. Infection can be transmitted within the patients’ environment; however, and because C. diff
spores are notoriously resilient against many common infection measures
, using cleaners specifically formulated to kill these bacteria can decrease that risk.
In a press release touting the additional EPA-registered kill claims for the products, Director of Marketing at Clorox Healthcare, Lynda Lurie, said, “At Clorox Healthcare, we are dedicated to safeguarding patient environments and continuously strive to ensure our surface disinfectants meet the needs of the ever-changing healthcare environment. We made these changes proactively so that healthcare professionals can be prepared for whatever comes through their doors, wherever care is delivered.”
Learn more about the new Clorox Healthcare products here